Hoping the reason Celgene backed out of the Bluebird deal is to partner up with BLCM. BLCM still has no real partner and all they need is a celegene, Novartis, etc. and it is off to the races. They do have their own switch which has it own medical designated classification. That is a big deal on it's own and with a 40% death rate in this field, they are more important than others. Just not noticed yet... Baker Bros. get's it... Just waiting on others.. Should or could be gigantic.. Juno is a ploy at best, a stock selling and pumping machine, Kite has the connections...
